1. Home
  2. VTGN vs CDLX Comparison

VTGN vs CDLX Comparison

Compare VTGN & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTGN
  • CDLX
  • Stock Information
  • Founded
  • VTGN 1998
  • CDLX 2008
  • Country
  • VTGN United States
  • CDLX United States
  • Employees
  • VTGN N/A
  • CDLX N/A
  • Industry
  • VTGN Biotechnology: Pharmaceutical Preparations
  • CDLX Computer Software: Programming Data Processing
  • Sector
  • VTGN Health Care
  • CDLX Technology
  • Exchange
  • VTGN Nasdaq
  • CDLX Nasdaq
  • Market Cap
  • VTGN 87.2M
  • CDLX 93.5M
  • IPO Year
  • VTGN N/A
  • CDLX 2018
  • Fundamental
  • Price
  • VTGN $3.52
  • CDLX $0.91
  • Analyst Decision
  • VTGN
  • CDLX Hold
  • Analyst Count
  • VTGN 0
  • CDLX 3
  • Target Price
  • VTGN N/A
  • CDLX $2.25
  • AVG Volume (30 Days)
  • VTGN 628.3K
  • CDLX 1.3M
  • Earning Date
  • VTGN 11-06-2025
  • CDLX 11-05-2025
  • Dividend Yield
  • VTGN N/A
  • CDLX N/A
  • EPS Growth
  • VTGN N/A
  • CDLX N/A
  • EPS
  • VTGN N/A
  • CDLX N/A
  • Revenue
  • VTGN $646,000.00
  • CDLX $266,201,000.00
  • Revenue This Year
  • VTGN $46.91
  • CDLX N/A
  • Revenue Next Year
  • VTGN $504.34
  • CDLX N/A
  • P/E Ratio
  • VTGN N/A
  • CDLX N/A
  • Revenue Growth
  • VTGN N/A
  • CDLX N/A
  • 52 Week Low
  • VTGN $1.90
  • CDLX $0.85
  • 52 Week High
  • VTGN $3.88
  • CDLX $5.25
  • Technical
  • Relative Strength Index (RSI)
  • VTGN 62.68
  • CDLX 32.85
  • Support Level
  • VTGN $3.01
  • CDLX $0.85
  • Resistance Level
  • VTGN $3.88
  • CDLX $1.12
  • Average True Range (ATR)
  • VTGN 0.21
  • CDLX 0.09
  • MACD
  • VTGN 0.02
  • CDLX 0.01
  • Stochastic Oscillator
  • VTGN 59.87
  • CDLX 18.96

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

About CDLX Cardlytics Inc.

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Share on Social Networks: